Senior Medical Strategy Manager
United Therapeutics Corporation
Summary
You are a strategic Medical Affairs professional who combines scientific expertise with operational excellence to drive evidence generation and advance patient care. You thrive in cross-functional environments, leading investigator-sponsored and strategic studies, building trusted relationships with investigators and KOLs, and translating complex data into meaningful insights that shape medical strategy and support innovative therapies.
Job description
Who You Are
You are a strategic Medical Affairs professional who combines scientific expertise with operational excellence to drive evidence generation and advance patient care. You thrive in cross-functional environments, leading investigator-sponsored and strategic studies, building trusted relationships with investigators and KOLs, and translating complex data into meaningful insights that shape medical strategy and support innovative therapies.
The Senior Medical Strategy Manager will manage and oversee day-to-day operational and scientific activities within medical affairs and ensure assigned Investigator Sponsored Studies (ISS) and data query programs are managed appropriately. Represent medical affairs interests and needs in multi-disciplinary teams (e.g. project teams, clinical study team meetings). Additionally, conduct and oversee small strategic studies by medical affairs.
- Oversee the ISS program in partnership with other Medical Affairs staff and provide scientific and operational support to enhance the ISS review, approval, documentation, and tracking processes
- Communicate with investigators in the ISS program and foster timely execution of newly approved and ongoing studies; lead quarterly data reviews of new data generated from ISS program
- Design, execute, and manage small strategic studies by medical affairs
- Provide operational oversight and manage external vendors/CRO for small strategic studies and non-interventional, minimal risk studies conducted by Medical Affairs; provide input for clinical operations/product development operations, as needed
- Prepare and present detailed tactics for phase IV data generation
- Collaborate with cross-functional teams to support products throughout their lifecycle (launch planning, medicine development plans, project team meetings, etc.)
- Generate material for Medical Affairs field teams and Advisory Board
- Stay abreast of developments and gather information and insight on Medical Affairs activities to leverage critical data and synthesize information for key stakeholders
- Perform back up medical technical reviews of promotional materials, sales training materials, and other material for external use (e.g. advisory board content and non-promotional reprints) by providing medical/scientific input, validation of data, and consistency and compliance with product package inserts, established guidelines, institutional laws, regulations and practices
- Collaborate with external HCPs, KOLs, and CROs to author scientific publications that further UT's medical strategy
Requirements
- Doctor of Philosophy (PhD), Doctor of Pharmacy (PharmD) or MD
- 5+ years of pharmaceutical/biotech company experience in Medical Affairs or a post-doc fellowship in Medical Affairs; Alternative pharma experience may be taken into consideration
- Excellent written and oral communication skills
- Excellent team building
- Ability to initiate and lead projects
- Record of accomplishment and increasing responsibility in scientific, clinical and/or pharmaceutical industry setting
- Solid working knowledge of word processing, spreadsheet, email and presentation software (MS Office suite)
- Ability to travel up to 35%
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Employee Stock Purchase Plan
- Employee Wellness Resources
- Paid Time Off
- Paid Parental Leave
- Disability Benefits
- Short-Term Incentive
- Long-Term Incentive
Company overview
United Therapeutics Corporation is an American biotechnology company founded in 1996 with a deeply personal mission: to find a cure for pulmonary arterial hypertension (PAH) after the founder's daughter was diagnosed with this rare disease. Headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, the company has evolved into a pioneering force in biotechnology, focusing on developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. United Therapeutics specializes in treatments for pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, neuroblastoma, and end-stage lung disease through its flagship products including Tyvaso, Remodulin, Orenitram, Adcirca, and Unituxin. The company is particularly notable for being the first publicly-traded biotech or pharmaceutical company to convert to a public benefit corporation (PBC), with a dual purpose of developing innovative pharmaceutical therapies and creating technologies that increase transplantable organ availability. Their groundbreaking work includes xenotransplantation research, organ manufacturing technologies, and regenerative medicine programs aimed at addressing critical shortages in transplantable organs. With approximately 1,001-5,000 employees and a strong commitment to corporate social responsibility, United Therapeutics has established itself as a leader in both patient-focused innovation and workplace excellence.